Curesponse has developed a 3-dimensional tissue culture system for modeling cancer growth and drug response. The platform, preserves the cancer tissue architecture (including vasculature and immune system) accurately reflecting the cancer growth found in the body.
Employees: 11-50
Total raised: $14M
Founded date: 2017
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 15.11.2021 | - | $8M | - | ncltv.co.u... |
| 05.06.2020 | Series A | $6M | - | amoon.fund... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 17.11.2021 | Curesponse Secures Additional USD 8 Million Funding for Its ... | REẖOVOT, Israel, November 15, 2021 (Newswire.com) – Curesponse (www.curesponse.com) has secured addi... | ncltv.co.u... |
| 15.11.2021 | Curesponse Secures Additional USD 8 Million Funding for Its ... | REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured addit... | globenewsw... |
| 15.11.2021 | Curesponse Secures Additional USD 8 Million Funding for Its ... | REẖOVOT, Israel, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Curesponse (www.curesponse.com) has secured addit... | marketscre... |
| 30.06.2020 | ‘Covid Put Everything On Steroids,’ Says Prominent Healthtec... | When VC aMoon was established in 2017, “the premise was to invest heavily in the convergence of tech... | forbes.com... |
| 05.06.2020 | Curesponse Secures $6M Series A for Breakthrough Precision M... | - | amoon.fund... |